83 related articles for article (PubMed ID: 7938903)
1. Blood cytokine and complement levels in patients with sepsis.
Takakuwa T; Endo S; Nakae H; Kikuchi M; Baba N; Inada K; Yoshida M
Res Commun Chem Pathol Pharmacol; 1994 Jun; 84(3):291-300. PubMed ID: 7938903
[TBL] [Abstract][Full Text] [Related]
2. Relationships between plasma levels of type-II phospholipase A2, PAF-acetylhydrolase, leukotriene B4, complements, endothelin-1, and thrombomodulin in patients with sepsis.
Takakuwa T; Endo S; Nakae H; Suzuki T; Inada K; Yoshida M; Ogawa M; Uchida K
Res Commun Chem Pathol Pharmacol; 1994 Jun; 84(3):271-81. PubMed ID: 7938901
[TBL] [Abstract][Full Text] [Related]
3. Plasma concentrations of type II phospholipase A2, cytokines and eicosanoids in patients with burns.
Nakae H; Endo S; Inada K; Yamashita H; Yamada Y; Takakuwa T; Kasai T; Ogawa M; Uchida K
Burns; 1995 Sep; 21(6):422-6. PubMed ID: 8554682
[TBL] [Abstract][Full Text] [Related]
4. Plasma levels of type II phospholipase A2 and cytokines in patients with sepsis.
Endo S; Inada K; Nakae H; Takakuwa T; Yamada Y; Suzuki T; Taniguchi S; Yoshida M; Ogawa M; Teraoka H
Res Commun Mol Pathol Pharmacol; 1995 Dec; 90(3):413-21. PubMed ID: 8746487
[TBL] [Abstract][Full Text] [Related]
5. PAF acetylhydrolase and arachidonic acid metabolite levels in patients with sepsis.
Takakuwa T; Endo S; Nakae H; Kikichi M; Inada K; Yoshida M
Res Commun Chem Pathol Pharmacol; 1994 Jun; 84(3):283-90. PubMed ID: 7938902
[TBL] [Abstract][Full Text] [Related]
6. [The relationship between opsonin, endotoxin and chemical mediators in postoperative complications after surgery].
Kawarada Y; Takagi K; Kuze M; Noguchi T; Mizumoto R
Nihon Geka Gakkai Zasshi; 1991 Sep; 92(9):1296-9. PubMed ID: 1944209
[TBL] [Abstract][Full Text] [Related]
7. Serum complement levels and severity of sepsis.
Nakae H; Endo S; Inada K; Takakuwa T; Kasai T; Yoshida M
Res Commun Chem Pathol Pharmacol; 1994 May; 84(2):189-95. PubMed ID: 8091004
[TBL] [Abstract][Full Text] [Related]
8. Complement C3 cleavage and cytokines interleukin-1beta and tumor necrosis factor-alpha in otitis media with effusion.
Närkiö-Mäkelä M; Teppo AM; Meri S
Laryngoscope; 2000 Oct; 110(10 Pt 1):1745-9. PubMed ID: 11037838
[TBL] [Abstract][Full Text] [Related]
9. Chronological changes in the complement system in sepsis.
Nakae H; Endo S; Inada K; Yoshida M
Surg Today; 1996; 26(4):225-9. PubMed ID: 8727941
[TBL] [Abstract][Full Text] [Related]
10. Functional modification of vascular endothelial cells by cytokines during septic shock.
Endo S; Inada K; Yamada Y; Takakuwa T; Nakae H; Kasai T; Koike S; Inoue Y; Niimi M; Wakabayashi G; Taniguchi S
Res Commun Mol Pathol Pharmacol; 1996 Oct; 94(1):23-38. PubMed ID: 8948012
[TBL] [Abstract][Full Text] [Related]
11. Platelet-activating factor (PAF) acetylhydrolase activity, type II phospholipase A2, and cytokine levels in patients with sepsis.
Endo S; Inada K; Yamashita H; Takakuwa T; Nakae H; Kasai T; Kikuchi M; Ogawa M; Uchida K; Yoshida M
Res Commun Chem Pathol Pharmacol; 1994 Mar; 83(3):289-95. PubMed ID: 8008978
[TBL] [Abstract][Full Text] [Related]
12. Endotoxin, interleukin-6 and phospholipase-A2 as markers of sepsis in patients with hematological malignancies.
Rintala E; Pulkki K; Mertsola J; Nevalainen T; Nikoskelainen J
Scand J Infect Dis; 1995; 27(1):39-43. PubMed ID: 7784812
[TBL] [Abstract][Full Text] [Related]
13. Interaction of prostaglandins, activated complement, and granulocytes in clinical sepsis and hypotension.
Slotman GJ; Burchard KW; Williams JJ; D'Arezzo A; Yellin SA
Surgery; 1986 Jun; 99(6):744-51. PubMed ID: 3520916
[TBL] [Abstract][Full Text] [Related]
14. Secretory non-pancreatic phopholipase A2 in severe sepsis: relation to endotoxin, cytokines and thromboxane B2.
Guidet B; Piot O; Masliah J; Barakett V; Maury E; Bereziat G; Offenstadt G
Infection; 1996; 24(2):103-8. PubMed ID: 8740100
[TBL] [Abstract][Full Text] [Related]
15. Complement activation and the production of inflammatory mediators during the treatment of severe sepsis in humans.
Dofferhoff AS; de Jong HJ; Bom VJ; van der Meer J; Limburg PC; de Vries-Hospers HG; Marrink J; Mulder PO; Weits J
Scand J Infect Dis; 1992; 24(2):197-204. PubMed ID: 1641597
[TBL] [Abstract][Full Text] [Related]
16. Assessment of inflammatory cytokines, nitrate/nitrite, type II phospholipase A2, and soluble adhesion molecules in systemic inflammatory response syndrome.
Takakuwa T; Endo S; Inada K; Kasai T; Yamada Y; Ogawa M
Res Commun Mol Pathol Pharmacol; 1997 Oct; 98(1):43-52. PubMed ID: 9434314
[TBL] [Abstract][Full Text] [Related]
17. Unopposed interleukin-1 is necessary for increased plasma cytokine and eicosanoid levels to develop in severe sepsis.
Slotman GJ; Quinn JV; Wry PC; Brathwaite CE; Friedman BM
Ann Surg; 1997 Jul; 226(1):77-84. PubMed ID: 9242341
[TBL] [Abstract][Full Text] [Related]
18. Relationship between cytokines and leukotriene B4 in sepsis.
Nakae H; Endo S; Inada K; Takakuwa T; Kasai T; Yoshida M
Res Commun Chem Pathol Pharmacol; 1994 Feb; 83(2):151-6. PubMed ID: 8202628
[TBL] [Abstract][Full Text] [Related]
19. Relationship between thromboxane B2 and 6-keto-prostaglandin F1 alpha in sepsis.
Nakae H; Endo S; Inada K; Takakuwa T; Kasai T; Yoshida M
Res Commun Chem Pathol Pharmacol; 1994 Mar; 83(3):297-302. PubMed ID: 8008979
[TBL] [Abstract][Full Text] [Related]
20. Relationship between plasma levels of type II phospholipase A2, PAF acetylhydrolase, endothelin-1, and thrombomodulin in patients with infected burns.
Takakuwa T; Endo S; Nakae H; Yamada Y; Inada K; Yoshida M; Ogawa M; Uchida K
Res Commun Mol Pathol Pharmacol; 1994 Dec; 86(3):335-40. PubMed ID: 7712109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
